The FDA has approved ciclesonide nasal spray (Omnaris, Altana Pharma), a corticosteroid for treating nasal symptoms associated with seasonal and perennial allergic rhinitis (hay fever) in adults and in children 12 years of age and older. The precise mechanism of action is unknown, although corticosteroids suppress the immune response. requip 2 mg The safety and [...]
It has been known today that generic Singulair is effective in preventing exercise-induced bronchoconstriction (EIB). According to the update facts by Merck & Co., Inc. a new indication is useful in patients aged 15 years and older. The efficacy of SINGULAIR 10 mg was investigated in three randomized, double-blind, placebocontrolled crossover studies in 160 patients [...]
Abbreviated New Drug Application (ANDA) for prescription Cetirizine Hydrochloride Syrup (cetirizine syrup) is produced by a multinational, science-based pharmaceutical company, called Taro Pharmaceutical Industries Ltd. This company had received experimental approval for this ANDA in October 2007 and today it has received final approval from the U.S. Food and Drug Administration (FDA). Generic Cetirizine syrup [...]
At the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Diego new investigation is presented. The aim of the study conducted by physicians in the Division of Allergy, Asthma and Immunology at Allegheny General Hospital (AGH) in Pittsburgh was to reveal if Singulair (Montelukast) drug may provide relief for the [...]
The US Food and Drug Administration (FDA) investigates a prescription drug Singulair (Montelukast) used in treating asthma and allergic rhinitis. It intends to reveal a potential link between the drug’s use and changes to behavior and mood, suicide, and suicidal thinking and behavior if it takes place. According to the announcement made on 27th of [...]
It has been proven that taking Singulair tablets once a day help relieve a variety of indoor and outdoor allergy symptoms for up to 24 hours. Gailen Marshall Jr., M.D., Ph.D., director of the Division of Clinical Immunology and Allergy at the University of Mississippi Medical Center in Jackson, MS, considers allergic rhinitis to be [...]
Today it has been known that New York (USA) Pfizer Inc and UCB Pharma confirmed a new chewable formulation of Zyrtec drug (cetirizine HCl). Cetirizine allergy medication is considered to be the number-one prescribed antihistamine by pediatricians and allergists for the treatment of seasonal and perennial allergic rhinitis (inflammation of the nasal passages) and chronic [...]
